-transparent.png){kind=logo}
We investigated the production of leukemia inhibitory factor (LIF) by human carcinoma cell lines. LIF mRNA was detected by Northern blot analysis in all 24 carcinoma cell lines of the lung, breast, stomach, colon, liver, gallbladder, pancreas and melanocytes. Seventeen of them (70.8%) secreted LIF in the culture supernatant (range: 40.4-3990.3 pg/ml, mean +/- SEM: 611.8 +/- 262.9 pg/ml). Biologic activity of LIF was confirmed in the culture supernatant of carcinoma cell lines by the MTT assay using M1 cells. The present results showed that human carcinoma cell lines are constitutively producing biologically active LIF. The possible biological significance of LIF produced by cancer cells is discussed.
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
January 2000,
Oral oncology,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
November 1999,
Nihon rinsho. Japanese journal of clinical medicine,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
July 2010,
Nihon rinsho. Japanese journal of clinical medicine,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
October 2015,
Cytokine & growth factor reviews,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
August 2005,
Nihon rinsho. Japanese journal of clinical medicine,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
September 2002,
Growth factors (Chur, Switzerland),
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
March 1991,
International journal of cell cloning,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
April 1999,
American journal of respiratory cell and molecular biology,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
August 1991,
Endocrine reviews,
H Kamohara, and
K Sakamoto, and
T Ishiko, and
S Mita, and
Y Masuda, and
T Abe, and
M Ogawa
February 1991,
International journal of cancer,
